Cadence Bank banner

Wall St Price Targets

BTO0 Price Targets Summary
Cadence Bank

There are no price targets for BTO0.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Cadence Bank Competitors:
Price Targets
CCCC
C4 Therapeutics Inc
172% Upside
BDTX
Black Diamond Therapeutics Inc
361% Upside
DOYU
Douyu International Holdings Ltd
12% Upside
TROX
Tronox Holdings PLC
-3% Downside
PCRX
Pacira Biosciences Inc
32% Upside

Revenue
Forecast

8% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
8% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 2 years is 9%.

Net Income
Forecast

21% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-49%
Average Miss
21% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-49%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 2 years is 16%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BTO0's stock price target?
Not Available

BTO0 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Cadence Bank?
Projected CAGR
9%

Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 2 years is 9%.

What is the Net Income forecast for Cadence Bank?
Projected CAGR
16%

Over the last 14 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 2 years is 16%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett